Thaci, D, K Papp, K Gordon, A Morita, M Gooderham, P Foley, E Alemano, R Kisa, Y Elbez, H Ren, and S Banerjee. “An Oral, Selective Tyrosine Kinase 2 Inhibitor, BMS-986165, Improves Quality of Life in Psoriasis: Results from a Phase 2 Study”. SKIN The Journal of Cutaneous Medicine 30 (November 9, 2019): S12. Accessed November 29, 2020. https://jofskin.org/index.php/skin/article/view/739.